6550--Blood Bank Tube Reagents

This Statement of Work outlines the requirements for a contractor to provide Alba Brand Tube method Blood Bank reagents to the Department of Veterans Affairs Pathology & Laboratory Medicine Service (P&LMS) at the G.V. (Sonny) Montgomery VAMC in Jackson, Mississippi. These reagents serve as a backup or supplemental testing method for essential transfusion medicine procedures, including type and screen, antibody identification, and crossmatches. Under the contract, the vendor must supply prepackaged, high-quality, and FDA-compliant reagent red blood cells on a standing order schedule every four weeks. Deliverables include specified quantities of A1, A2, and B cells, antibody screening and identification panels, IgG sensitized cells, C3 coated cells, and quality control kits. Reagents must be shipped in original sealed containers to maintain integrity, and the contractor must provide open-date stability details, replacement policies, and technical bulletins or recall alerts. The contractor is subject to strict federal regulations, including National Archives and Records Administration (NARA) records management standards, and must complete mandatory VA records management training. Additionally, all products and services must comply with quality and safety standards established by governing bodies such as the FDA, CLIA, CAP, and the Association for the Advancement of Blood & Biotherapies (AABB). No installation or security accreditation package is required for this contract.

The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 16, has issued a Sources Sought Notice (SSN) to conduct market research for an upcoming procurement of Alba brand blood bank tube reagents. The primary objective is to identify qualified and capable sources to determine an appropriate acquisition strategy, such as a small business set-aside. The requirement falls under NAICS code 325413 (In Vitro Diagnostic Substance Manufacturing). To be considered responsive, interested vendors must submit specific information. This includes identifying where the Alba reagents are manufactured, providing official Original Equipment Manufacturer (OEM) authorization confirming distributor status with access to genuine inventory, and indicating business size and certifications (such as SDVOSB, VOSB, HUBZone, or 8(a)). Resellers must also demonstrate compliance with the Nonmanufacturer Rule (NMR). Additionally, vendors should provide company contact information, relevant contract vehicles (GSA, GWAC, IDIQ), and estimated market pricing. Questions regarding this notice are due by July 14, 2026, and final responses must be submitted via email to William Shaver (William.Shaver@va.gov) by 07:00 AM CST on July 15, 2026. If no authorized distributors respond, the VA intends to pursue a sole-source award to the manufacturer or an established authorized distributor.

This Sources Sought Notice (Solicitation Number 36C25626Q1037) is issued by the Department of Veterans Affairs, Network Contracting Office 16, to identify potential sources for providing blood bank tube reagents. The contracted items will support operations at the G.V. (Sonny) Montgomery VA Medical Center located in Jackson, Mississippi. Key details of the notice include a response deadline of July 15, 2026, at 7:00 AM Central Time. The procurement is classified under Product Service Code 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits, and Sets) and NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing). Interested parties can review the attached draft Statement of Work (Attachment A) and the primary Sources Sought document for comprehensive technical requirements and background information. William Shaver, the designated Contract Specialist, is the primary point of contact for this market research effort.